1,2-dimethylhydrazine multiple interactions ISO RGD:1550757 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SGK3 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1354188 6480464 Estradiol results in increased expression of SGK3 mRNA CTD PMID:26865669 , PMID:28711546 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1354188 6480464 Dihydrotestosterone results in increased expression of SGK3 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550757 6480464 Tetrachlorodibenzodioxin affects the expression of SGK3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550757 6480464 Tetrachlorodibenzodioxin results in decreased expression of SGK3 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SGK3 mRNA CTD PMID:32109520 , PMID:34747641 4,4'-diaminodiphenylmethane increases expression ISO RGD:1550757 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SGK3 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1550757 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SGK3 mRNA CTD PMID:30951980 4-nitrophenol increases expression ISO RGD:1550757 6480464 4-nitrophenol results in increased expression of SGK3 mRNA CTD PMID:34673133 acrylamide increases expression ISO RGD:1354188 6480464 Acrylamide results in increased expression of SGK3 mRNA CTD PMID:32763439 afimoxifene decreases response to substance ISO RGD:1354188 6480464 SGK3 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1354188 6480464 Aflatoxin B1 affects the expression of SGK3 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1354188 6480464 Aflatoxin B1 results in decreased methylation of SGK3 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1354188 6480464 Aflatoxin B1 results in decreased expression of SGK3 mRNA CTD PMID:21632981 , PMID:21641981 all-trans-retinoic acid increases expression ISO RGD:1354188 6480464 Tretinoin results in increased expression of SGK3 mRNA CTD PMID:21934132 , PMID:33167477 antirheumatic drug decreases expression ISO RGD:1354188 6480464 Antirheumatic Agents results in decreased expression of SGK3 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1354188 6480464 Arsenic affects the methylation of SGK3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1354188 6480464 Arsenic affects the methylation of SGK3 gene CTD PMID:25304211 barium(0) multiple interactions ISO RGD:1354188 6480464 Barium inhibits the reaction [SGK3 protein results in increased transport of Potassium] CTD PMID:12590200 belinostat increases expression ISO RGD:1354188 6480464 belinostat results in increased expression of SGK3 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1354188 6480464 Benzo(a)pyrene results in decreased expression of SGK3 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:1354188 6480464 Benzo(a)pyrene affects the methylation of SGK3 5' UTR, Benzo(a)pyrene affects the methylation of SGK3 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1550757 6480464 Benzo(a)pyrene results in decreased expression of SGK3 mRNA CTD PMID:20127859 , PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1354188 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression ISO RGD:1550757 6480464 bisphenol A results in decreased expression of SGK3 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1354188 6480464 bisphenol A results in decreased expression of SGK3 mRNA CTD PMID:33670352 bisphenol A increases expression ISO RGD:1550757 6480464 bisphenol A results in increased expression of SGK3 mRNA CTD PMID:34585602 bisphenol A increases expression ISO RGD:1354188 6480464 bisphenol A results in increased expression of SGK3 mRNA CTD PMID:28711546 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SGK3 mRNA CTD PMID:25181051 cadmium atom multiple interactions ISO RGD:1354188 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SGK3 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1354188 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SGK3 mRNA CTD PMID:35301059 CGP 52608 multiple interactions ISO RGD:1354188 6480464 CGP 52608 promotes the reaction [RORA protein binds to SGK3 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1550757 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SGK3 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1354188 6480464 Cisplatin results in decreased expression of SGK3 mRNA CTD PMID:27392435 clomiphene decreases expression ISO RGD:1354188 6480464 Clomiphene results in decreased expression of SGK3 mRNA CTD PMID:26865669 cocaine increases expression ISO RGD:1354188 6480464 Cocaine results in increased expression of SGK3 mRNA CTD PMID:18000554 copper(II) sulfate decreases expression ISO RGD:1354188 6480464 Copper Sulfate results in decreased expression of SGK3 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1354188 6480464 Coumestrol results in increased expression of SGK3 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1354188 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SGK3 mRNA CTD PMID:26577399 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SGK3 mRNA CTD PMID:27523638 diethylstilbestrol increases expression ISO RGD:1354188 6480464 Diethylstilbestrol results in increased expression of SGK3 mRNA CTD PMID:26865669 dorsomorphin multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1354188 6480464 [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3, 2-d)pyrimidine co-treated with Doxorubicin] results in decreased phosphorylation of SGK3 protein CTD PMID:20826841 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SGK3 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1354188 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1354188 6480464 entinostat results in increased expression of SGK3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 estrone increases expression ISO RGD:1354188 6480464 Estrone results in increased expression of SGK3 mRNA CTD PMID:26865669 ethanol affects expression ISO RGD:1550757 6480464 Ethanol affects the expression of SGK3 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1550757 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fulvestrant decreases expression ISO RGD:1354188 6480464 fulvestrant results in decreased expression of SGK3 mRNA CTD PMID:26865669 genistein increases expression ISO RGD:1354188 6480464 Genistein results in increased expression of SGK3 mRNA CTD PMID:26865669 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SGK3 mRNA CTD PMID:33387578 glyphosate decreases expression ISO RGD:1354188 6480464 glyphosate results in decreased expression of SGK3 mRNA CTD PMID:31295307 hexestrol increases expression ISO RGD:1354188 6480464 Hexestrol results in increased expression of SGK3 mRNA CTD PMID:26865669 L-methionine multiple interactions ISO RGD:1550757 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SGK3 gene CTD PMID:20938992 mercury dibromide increases expression ISO RGD:1354188 6480464 mercuric bromide results in increased expression of SGK3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 mestranol increases expression ISO RGD:1354188 6480464 Mestranol results in increased expression of SGK3 mRNA CTD PMID:26865669 methamphetamine decreases expression ISO RGD:1550757 6480464 Methamphetamine results in decreased expression of SGK3 mRNA CTD PMID:26307267 methyl methanesulfonate increases expression ISO RGD:1354188 6480464 Methyl Methanesulfonate results in increased expression of SGK3 mRNA CTD PMID:23649840 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of SGK3 mRNA CTD PMID:22546817 ouabain multiple interactions ISO RGD:1354188 6480464 Ouabain inhibits the reaction [SGK3 protein results in increased transport of Potassium] CTD PMID:12590200 panobinostat multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1354188 6480464 panobinostat results in increased expression of SGK3 mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SGK3 mRNA CTD PMID:33387578 paraquat increases expression ISO RGD:1550757 6480464 Paraquat results in increased expression of SGK3 mRNA CTD PMID:21463325 phenylmercury acetate increases expression ISO RGD:1354188 6480464 Phenylmercuric Acetate results in increased expression of SGK3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1550757 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGK3 mRNA CTD PMID:19710929 potassium atom multiple interactions ISO RGD:1354188 6480464 Barium inhibits the reaction [SGK3 protein results in increased transport of Potassium], Ouabain inhibits the reaction [SGK3 protein results in increased transport of Potassium] CTD PMID:12590200 potassium atom increases transport ISO RGD:1354188 6480464 SGK3 protein results in increased transport of Potassium CTD PMID:12590200 progesterone increases expression ISO RGD:1354188 6480464 Progesterone results in increased expression of SGK3 mRNA CTD PMID:18070364 quercetin decreases expression ISO RGD:1354188 6480464 Quercetin results in decreased expression of SGK3 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:1354188 6480464 Raloxifene Hydrochloride results in decreased expression of SGK3 mRNA CTD PMID:26865669 resveratrol multiple interactions ISO RGD:1354188 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SGK3 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases methylation ISO RGD:1550757 6480464 sodium arsenite results in decreased methylation of SGK3 gene CTD PMID:32068019 sodium arsenite decreases expression ISO RGD:1354188 6480464 sodium arsenite results in decreased expression of SGK3 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:1550757 6480464 sodium arsenite results in decreased expression of SGK3 protein CTD PMID:29044176 streptozocin increases expression ISO RGD:1550757 6480464 Streptozocin results in increased expression of SGK3 mRNA CTD PMID:16116964 testosterone enanthate affects expression ISO RGD:1354188 6480464 testosterone enanthate affects the expression of SGK3 mRNA CTD PMID:17440010 thapsigargin decreases expression ISO RGD:1550757 6480464 Thapsigargin results in decreased expression of SGK3 protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SGK3 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:1550757 6480464 titanium dioxide results in decreased expression of SGK3 mRNA CTD PMID:29264374 trichostatin A increases expression ISO RGD:1354188 6480464 trichostatin A results in increased expression of SGK3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1550757 6480464 triptonide results in decreased expression of SGK3 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1354188 6480464 Valproic Acid affects the expression of SGK3 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1354188 6480464 Valproic Acid results in decreased methylation of SGK3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1354188 6480464 Valproic Acid results in increased expression of SGK3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:1354188 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1354188 6480464 vorinostat results in increased expression of SGK3 mRNA CTD PMID:26272509